Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar jahjimhall (< 20) Submitted: 12/30/2010 6:38:05 PM : Underperform Start Price: $6.83 FLML Score: +41.10

No new drugs for a long time....

Featured Broker Partners


Advertisement